Abstract
BACKGROUND: Clinical stage cT3a renal cell carcinoma commonly prompts radical nephrectomy, but overdiagnosis of local invasion occurs in 5–10%. Unnecessary nephrectomy causes loss of functional parenchyma and chronic kidney disease risk. Available tools assess anatomical complexity but fail to definitively confirm pT3a, leaving interpretation to the clinician. AIM: To assess the rate and pattern of overstaging of clinical stage cT3a renal cell carcinoma and to demonstrate the clinical application of an online calculator, developed from these data, for predicting the true pathological stage pT3a. METHODS: The study included 703 patients with cT3a stage renal cell carcinoma who underwent surgical treatment between 2014 and 2025. Among 629 patients with histologically verified renal cell carcinoma, groups of pathologically confirmed pT3a ( n = 243) and overstaging cT3a → pT1–2 ( n = 386) were identified; in an extended cohort ( n = 689), 60 additional cases of understaging (cT1–2 → pT3a) were identified. Groups were compared by clinico-anatomical characteristics. Based on a previously developed combined clinico-radiomic model (area under the curve (AUC) = 0.89), a publicly available online calculator for preoperative prediction of pT3a probability was created. RESULTS: The overstaging rate of clinical stage cT3a was 61.4 % (386/629): only 38.6 % of patients had morphologically confirmed pT3a. The overstaging group differed significantly from the confirmed pT3a group in R.E.N.A.L. score (9 vs 10 points; p 3–4 (21.5 % vs 35.9 %; p CONCLUSION: The high rate of overstaging of clinical stage cT3a justifies the need for objective preoperative prediction tools. The developed online calculator provides a practical, real-time application of the clinico-radiomic model directly during preoperative patient counseling.